Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides...
9 insider purchases on record · latest filing 2023-02-24.
Insiders have also filed 116 sale transactions at VYGR.